Week Adjourned: 5.14.10
This week it’s all about bad employers and bad drugs…bad, bad, bad! Top Class Actions Whole New Meaning to Visitation Rights. A massive, nationwide class action lawsuit was filed this week by employees...
View ArticleAvandia Study Conflicts – and Conflicts of Interest?
So after the latest two Avandia studies came out earlier this week, we then see a third Avandia study—this one will also be debating fodder for the advisory panels at the FDA’s July meeting—the one...
View ArticleBig Pharma Lawsuits – Who Got Hit with the Biggest Settlement?
It seems that every month practically, one pharmaceutical company or another makes the news for bending rules around marketing. Mis-marketing, which could also be called consumer fraud, can result in...
View ArticleWeek Adjourned: 10.29.10
Top Class Actions What’s the word de jour? Foreclosure—actually—make that Foreclosure Class Actions. This week saw several foreclosure lawsuits filed against big banks. Possibly the most recent, was...
View ArticleWhistle while you Work? Sad Reality in American Business
Anyone who is aghast at the recent $750 million GlaxoSmithKline (Glaxo) whistleblower judgment to settle manufacturing deficiencies at a former plant in Puerto Rico shouldn’t be surprised that such...
View ArticleWhistleblower Lawsuit Pays Off Big For Former GSK Employee
Talk about your big payouts. A woman who acted as a whistleblower against GlaxoSmithKline will receive a whopping $96 million for her role in bringing the company to justice. Who knows, maybe...
View Article2010: Annus Horribilis for GlaxoSmithKline?
Let’s face it, lots of drug companies face a variety of lawsuits and fines from the government. But 2010 might be a year that GlaxoSmithKline would wipe from its memory if it could—a sort of annus...
View ArticleWeek Adjourned: 2.4.11
Top Class Actions Phantom of the iPhone. Do you have a phantom AT&T account? It seems for every new technological gadget that requires connectivity—there’s an opportunity to take advantage. Most...
View ArticleHot Potato Diet Drug Alli Up for Grabs, but Who’s Buying?
On the heels of consumer watchdog group, Public Citizen, calling for a ban of diet drug Alli, we see that GlaxoSmithKline (GSK)—makers of well-known type 2 and last-resort diabetes drug, Avandia—has...
View ArticleClik here to view.
Toothpaste Lawsuit over Blob Settles…so Who’s Got the Nurdle?
Toothpaste blob lawsuit settlement - the dramatic courtroom battle over toothpaste nurdle rights has reached its incredible denouement.
View ArticleRally in Denver for Ten Year Anniversary of Columbine
Ten years ago this month the violence and suicide caused by SSRI antidepressants gained international recognition in headlines all over the world when it became known that one of the teen shooters at...
View ArticleAvandia and Alzheimer’s…What If?
So here’s an interesting twist. Avandia, also known as rosiglitazone, once GlaxoSmithKline’s (GSK) blockbuster diabetes drug that turned out to be not so good for you after all, has failed to prove...
View Article7 Game-Changing Settlements of 2009
We’re in the countdown to year-end and looking over some of the more impactful settlements LawyersAndSettlements.com has covered over the past year. When we’re talking impactful, everyone around here...
View Article
